ReShape Lifesciences (RSLS) Climbs 3.99% on May 13

Equities Staff  |

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose 3.99% Friday.

As of 11:56:14 est, ReShape Lifesciences sits at $0.72 and has moved $0.0275 so far today.

ReShape Lifesciences has moved 41.18% over the last 30 days and has a YTD change of 57.93% based on the previous close.

The company expects its next earnings on 2022-05-16.

For technical charts, analysis, and more on ReShape Lifesciences visit the company profile.

About ReShape Lifesciences Inc.

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

To get more information on ReShape Lifesciences Inc. and to follow the company's latest updates, you can visit the company's profile page here: ReShape Lifesciences Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content